VX-398

N/A

Report date: 2023/03/21 14:37:41
NME

Base Information

Drug NameVX-398
Drug Alias NameVX-398
ClassificationSmall molecules
Mechanisms of ActionStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals IncorporatedNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A